We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




HIV Relies on Host Proteins to Clear the Way to the Nucleus

By LabMedica International staff writers
Posted on 06 Jul 2016
Print article
Image: HIV-1 viral cores (red) accumulate around the cell nucleus (blue) but remain unable to enter following depletion of the motor protein KIF5B (Photo courtesy of Loyola University Chicago).
Image: HIV-1 viral cores (red) accumulate around the cell nucleus (blue) but remain unable to enter following depletion of the motor protein KIF5B (Photo courtesy of Loyola University Chicago).
The ability of HIV to transit the cytoplasm and enter the nucleus of an infected cell was found to depend on the combined activities of two host proteins, the Kinesin-1 motor protein, KIF5B, and the nuclear pore component Nup358.

Following envelope mediated fusion, the HIV-1 nuclear core is released into the cytoplasm of the target cell and undergoes a series of modifications that result in the nuclear import of the viral genome, which ultimately leads to the integration of viral DNA into the host cell genome. Previous studies had found that disruption of microtubules, or depletion of dynein or kinesin motor proteins, perturbed the normal uncoating and trafficking of the viral genome.

In the current study, which was published in the June 21, 2016, online edition of the journal PLOS Pathogens, investigators at Loyola University (Chicago, IL, USA) enhanced the understanding of how HIV infection progresses by showing that the Kinesin-1 motor protein, KIF5B, induced a relocalization of the nuclear pore component Nup358 into the cytoplasm during HIV-1 infection. This relocalization of NUP358 was dependent on the HIV-1 capsid. NUP358 directly associated with viral cores following cytoplasmic translocation.

The interaction between NUP358 and the HIV-1 core was dependent on multiple capsid binding surfaces, as this association was not observed following infection with capsid mutants in which a conserved hydrophobic binding pocket (N74D) or the cyclophilin A binding loop (P90A) was disrupted. KIF5B knockdown also prevented the nuclear entry and infection by HIV-1, but did not exert a similar effect on the N74D or P90A capsid mutants, which do not rely on Nup358 for nuclear import.

Results obtained during these studies revealed a novel role for the microtubule motor protein KIF5B in the nuclear import of the viral genome and identified potential drug therapeutic intervention targets.

Related Links:
Loyola University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The fastGEN BCR::ABL1 Cancer kit offers a way to personalize treatment strategies for leukemia (Photo courtesy of BioVendor MDx)

First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment

The BCR::ABL1 fusion gene plays a key role in the pathogenesis of several blood cancers, particularly chronic myeloid leukemia (CML). This gene results from a chromosomal translocation that causes constitutive... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.